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Ornipressin in the Treatment of 
Functional Renal Failure in 
Decompensated Liver Cirrhosis 
Effects on Renal Hemodynamics and Atrial 
Natriuretic Factor 
K U R T L E N Z , H E I D E H Ö R T N A G L , W I L F R E D D R U M L , 
H A R A L D R E I T H E R , R A I N E R S C H M I D , B R U N O S C H N E E W E I S S , 
A N T O N L A G G N E R , G E O R G G R I M M , and A L E X A N D E R L . G E R B E S 
1st Department of Internal Medicine, Institute of Biochemical Pharmacology; Department of 
Psychiatry, University of Vienna, Vienna, Austria ; and Department of Medicine I I , K l i n i k u m 
Großhadern, University of M u n i c h , M u n i c h , Germany 
In 11 patients with decompensated cirrhosis and 
deteriorating renal function, the effect of the vasocon-
strictor substance 8-ornithin vasopressin (ornipres-
sin; POR 8; Sandoz, Basel, Switzerland) on renal 
function, hemodynamic parameters, and humoral 
mediators was studied. Ornipressin was infused at a 
dose of 6 IU/h over a period of 4 hours. During 
ornipressin infusion an improvement of renal func-
tion was achieved as indicated by significant in-
creases in inulin clearance (+65%), paraaminohip-
puric acid clearance (+49%), urine volume (+45%), 
sodium excretion (+259%), and fractional elimina-
tion of sodium ( + 130%). The hyperdynamic circula-
tion was reversed to a nearly normal circulatory 
state. The increase in systemic vascular resistance 
(+60%) coincided with a decrease of a previously 
elevated renal vascular resistance (-27%) and in-
crease in renal blood flow (+44%). The renal frac-
tion of the cardiac output increased from 2.3% to 
4.7% [P < 0.05). A decline of the elevated plasma 
levels of noradrenaline (2.08-1.13 ng/mL; P < 0.01) 
and renin activity (27.6-14.2 ng • mL"1 • h" 1 ; P < 
0.01) was achieved. The plasma concentration of the 
atrial natriuretic factor increased in most of the 
patients, but slightly decreased in 3 patients. The 
decrease of renal vascular resistance and the in-
crease of renal blood flow and of the renal fraction of 
cardiac output play a key role in the beneficial effect 
of ornipressin on renal failure. These changes de-
velop by an increase in mean arterial pressure, the 
reduction of the sympathetic activity, and probably 
of an extenuation of the splanchnic vasodilation. A 
significant contribution of atrial natriuretic factor is 
less likely. The present findings implicate that treat-
ment with ornipressin represents an alternative 
approach to the management of functional renal 
failure in advanced liver cirrhosis. 
Increasing evidence indicates that the use of vasocon-strictor substances represents a promising ap-
proach in the treatment of renal failure i n advanced 
liver cirrhosis (1). A n improvement of renal function 
has been achieved by administration of either a -sym-
pathomimetic drugs (2-4) or the vasopressin ana-
logues octapressin (5,6) and more recently 8-ornithin 
vasopressin (ornipressin) (7,8). A normalization of 
sodium and water excretion has also been achieved by 
central blood volume expansion wi th head-out water 
immersion i n combination w i t h a noradrenaline infu-
sion (9,10). 
U s i n g a vasoconstrictor compound i n advanced 
hepatic failure, one is confronted w i t h the phenome-
non of a pronounced arterial vasodilation i n the 
systemic circulation that is counteracted by a pro-
found vasoconstr ic t ion i n the renal vasculature 
(11,12). T h e renal vasoconstriction is, at least partly, 
related to an increased sympathetic tone i n the kid-
ney, because the blockade of the lumbal part of the 
sympathetic nerves that innervate the kidney im-
Abbreviations used in this paper: ANF, atrial natriuretic 
factor; FENa, fractional elimination of sodium; PAH, paraamino-
hippuric acid. 
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proved renal function i n cirrhotic patients (13). T h e 
obvious paradox of using a vasoconstrictor com-
pound i n the treatment of renal dysfunction that 
coincides w i t h a profound vasoconstriction of the 
renal vasculature needs further clarification. Periph-
eral arterial vasodilation, w h i c h appears to be most 
excessive i n the splanchnic territories, has been postu-
lated to play a key role in the development of the 
circulatory derangement and renal failure i n ad-
vanced liver cirrhosis (12,14-17) . A n efficient treat-
ment of this circulatory derangement therefore re-
quires a vasoconstrictor substance w i t h a preferential 
action i n the splanchnic vascular bed. I n this respect, 
vasopressin or its analogues w i t h reduced antidi-
uretic activity might be of considerable advantage 
because vasopressin is a m u c h more potent vasocon-
strictor of i l iac and mesenteric than of renal beds 
(18,19). I n decompensated cirrhosis, ornipressin has 
been s h o w n to increase creatinine clearance, urine 
volume, and sodium excretion and to normalize the 
hyperdynamic circulation (7). However, its effect on 
renal hemodynamics is less clear. A variable improve-
ment of renal perfusion in cirrhotic patients was 
achieved using octapressin (5,6). Preliminary data 
also indicate an improvement of renal hemodynamics 
during ornipressin infusion (20). 
T o achieve a better insight into the mechanisms 
involved i n the ameliorating effect of vasoconstrictor 
drugs on renal function in advanced liver disease w e 
investigated the influence of ornipressin on various 
indices of renal function and renal hemodynamics in 
cirrhotic patients with functional renal failure. I n 
addition, the influence of ornipressin on endogenous 
systems that have a considerable impact on renal 
function, namely the atrial natriuretic factor (ANF) as 
w e l l as the renin-angiotensin and sympathetic ner-
vous systems, was analyzed. 
Patients and Methods 
Patients 
Eleven patients (3 women, 8 men) with decompen-
sated alcoholic cirrhosis of the liver with severe impairment 
of renal function and spironolacton-resistant ascites en-
tered the study. They had been admitted to the intensive 
care unit because of deteriorating renal function despite 
volume expansion. The mean age was 48 years (38-58 
years). All patients had impaired liver function: serum 
Cholinesterase <1.0 U/L (normal range , 2.2-3.8 U/L), pro-
thrombin ratio <0.45 (of normal), bilirubin >2.5 mg/100 
mg, and albumin <2.8 g/L. The impairment of renal 
function was indicated by a creatinine clearance below 40 
ml • m i n - 1 • 1.73 m" 2 body surface area. The fractional 
elimination of sodium (FENa) was below 1% and all pa-
tients had ascites. Hypovolaemia was excluded by a central 
venous pressure > 5 mm Hg. Patients with severe imbal-
ances of serum electrolytes did not participate in the study. 
The serum concentrations of electrolytes before the onset of 
ornipressin infusion were potassium, 4.1 ± 0.3 and sodium, 
135 ± 3 mval. 
All patients received spironolactone (100 mg twice daily 
PO) for more than 4 weeks before admission to the hospital. 
Because of deterioration of renal function the dose was 
increased to 200 mg IV twice daily, at least 5 days before the 
study and maintained during the study. None of the pa-
tients had received any additional diuretic therapy for at 
least 5 days. Nine patients improved during intensive care, 
two patients deteriorated, and finally died in coma. Liver 
cirrhosis was confirmed by biopsy or necropsy samples in 
all patients. 
Protocol of the Study 
The study was started at 8 A M at least 24 hours after 
admission of the patient to the intensive care unit. After a 
2-hour preperiod, ornipressin (POR 8; Sandoz, Bale, Switzer-
land) was continuously infused at a dose of 6 IU/h via a 
central venous catheter over a period of 4 hours, using an 
infusion pump (Perfusor; Braun Melsungen, Melsungen, 
Germany). This was followed by an observation period of 2 
hours (postperiod). During the study, parenteral nutrition 
adapted for liver failure was continued (infusion rate: 1 
mL • k g - 1 • h " \ sodium 40 mmol/L). 
The study was performed according the principles of the 
declaration of Helsinki, and informed consent was obtained 
in every case. The consent form had been reviewed and 
approved by the Ethical Committee of the Department of 
Internal Medicine. If the patient was unable to understand 
the nature of the procedures, the family members were 
specifically informed. 
Clinical Tests 
Hemodynamic monitoring was performed using a 
femoral artery catheter and a percutaneously inserted 7F 
flow-directed thermodilution pulmonary artery catheter 
(Gould SP 5507; Gould, Oxnard, CA). Cardiac output was 
estimated by the thermodilution technique with 10 ml of a 
5% solution of dextrose in water at 0°C (Gould Cardiac 
Output Computer). All measurements were performed in 
triplicate and averaged. The intravascular pressures were 
calibrated against a mercury sphygmomanometer and were 
recorded by Gould transducer SP50 (with the midaxillary 
line as zero reference) and a Hewlett-Packard multichannel 
recorder (Hewlett-Packard, Waltham, MA). The values were 
averaged at the end of exspiration for three successive 
respiratory cycles. Mean pressures were derived by elec-
tronic integration. Systemic vascular resistance was calcu-
lated from a standard formula (21). Hemodynamic data 
were recorded before the infusion of ornipressin, 2 and 4 
hours after the start of the infusion and 2 hours after the end 
of the infusion. 
Urine was collected via a transurethral catheter in 2-hour 
periods for measurement of urine osmolality and sodium 
and creatinine concentrations. Serum osmolality and so-
dium and creatinine concentrations were measured before 
and at the end of ornipressin infusion. The concentration of 
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creatinine and sodium were determined by standard photo-
metric methods (ACA, Wilmington, DE). The osmolality 
was measured by the freezing point method (Osmomat 030; 
Genotec, Berlin, Germany). Creatinine clearance, free water 
clearance and FENa were calculated using standard formu-
las (22). 
Paraaminohippuric acid (PAH) and inulin clearance were 
determined according to standard methods in 8 patients. A n 
IV loading dose of sodium PAH (Nephrotest; Lieh, Hessen, 
Germany; 6 mg/kg) or polyfructosan (inulin; Inutest, Lae-
vosan, Linz, Austria; 30 mg/kg) was followed by a continu-
ous infusion at a rate of 30 mL/h (PAH, 22 mg/mL; polyfruc-
tosan, 40 mg/ml). Renal plasma flow and renal blood flow 
were calculated according to a standard formula (23). Renal 
fraction was determined by the ratio of cardiac output to 
renal blood flow. Filtration fraction was derived from the 
ratio of inulin clearance to renal plasma flow. Renal vascu-
lar resistance was calculated from the difference of mean 
arterial pressure and central venous pressure divided by the 
renal blood flow. 
Biochemical Analyses 
For analysis of the plasma level of noradrenaline, 
adrenaline and plasma renin activity arterial blood samples 
(femoral artery) in eight and nine patients, respectively, and 
for the determination of the ANF immunoreactivity, blood 
samples from the right atrium were collected in 10 patients 
before the start of the ornipressin infusion and 2 hours later 
into precooled heparinized tubes (for noradrenaline and 
adrenaline) and precooled tubes coated with sodium ethyl-
enediaminetetraacetic acid (for ANF and plasma renin 
activity). Plasma was separated by centrifugation at +2°C 
and stored at - 2 0 ° C until estimation. 
Plasma levels of adrenaline and noradrenaline were 
analyzed after solvent extraction by high performance 
liquid chromatography with coulometric electrochemical 
detection (ESA Coulochem, Model 5100A; Bedford, MA). 
For the extraction of catecholamines from plasma (1-2 mL 
aliquots) the procedure described by Bauch et al. (24) with 
minor modifications was used. The concentration of tetraoc-
tylammonium bromide in mixture B was reduced to 1.2 
mmol/L. As an internal standard, a-methyldopamine was 
added to the plasma sample before extraction. Chromato-
graphic separation was achieved on a Nucleosil 5 SA 
column (130 x 4.6 mm ID; Macherey-Nagel, Düren, Ger-
many). The mobile phase contained 100 mmol/L sodium 
acetate, 60 mmol/L sodium hydroxide, 40 mmol/L citric 
acid, and 10% methanol. The final pH was adjusted to 5.2 
and the mobile phase was pumped at a flow rate of 1 
mL/min. Plasma renin activity and ANF were measured by 
radioimmunoassays (25,26). 
Data Analysis 
Data are expressed as mean values ± SEM. Statisti-
cal analyses were carried out by means of analysis of 
variance followed by Tukey's studentized range test. For 
comparing two pairs of measures, the paired Student's t test 
was applied. A significance level of P < 0.05 was chosen. 
Results 
Hemodynamic Changes 
T h e effect of ornipressin on various hemody-
namic parameters is summarized i n Table 1. Before 
the onset of ornipressin infusion a hyperdynamic 
circulatory state, characteristic for liver failure ( 2 7 -
29), w i t h increased cardiac output and decreased 
mean arterial pressure, was observed. These changes 
i n systemic circulation were associated w i t h a de-
crease i n renal plasma flow and i n renal fraction 
(proportion of cardiac output delivered to the kidney) . 
During ornipressin infusion, the hypercirculatory state 
was reversed to an almost normal circulation accom-
panied by a significant increase i n renal plasma flow 
and renal fraction. I n addition, ornipressin caused a 
significant increase i n pulmonary capillary wedge 
pressure, whereas the central venous pressure i n -
creased only slightly, without reaching the level of 
significance. T h e cardiovascular improvement pre-
sisted only as long as ornipressin w a s infused. I n spite 
of a considerable increase of the lowered systemic 
vascular resistance from 545 ± 39 to 912 ± 130 dyne • 
s" 1 • c m 5 ; P < 0.02) renal vascular resistance de-
Tabie 1. Hemodynamic Changes During Ornipressin Infusion 
Ornipressin 
Preperiod + 2 hours + 4 hours Postperiod Control values 
Heart rate [beats!min) 104 ± 4 75 ± 3° 76 ± 4° 92 ± 6 78 ± 4 b 
Pulmonary capillary wedge pressure (mm Hg) 11 ± 1 14 ± 1° 15 ± 1° 9 ± 1 12 ± l b 
Central venous pressure [mm Hg) 8 ± 1 10 ± 1 10 ± 1 8 ± 2 6 ± l b 
Mean arterial pressure (mm Hg) 81 ± 3 100 ± 4° 95 ± 4° 77 ± 4 91 ± 3b 
Cardiac output (LImin) 10.8 ± 1.0 8.4 ± 0.7° 8.3 ± 0.8° 10.0 ± 0.8 6.6 ± 0.5b 
Renal plasma f low (mL/min) 195 ± 40 290 ± 61° 273 ± 38° 207 ± 39 574 ± 35 c 
Renal fraction (of cardiac output) (%) 2.3 ± 0.4 4.7 ± 1.0° 4.5 ± 0.7° 3.0 ± 0.5 16 ± 2C 
NOTE. n = 11. 
°P < 0.05 vs. preperiod. 
^Control values taken f rom Barrat-Boyes and Wood (57). 
c Control values taken f r o m Davies and Schock (58). 
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Figure 1. Changes in renal and sys-
temic vascular resistance in response to 
ornipressin infusion. The normal upper 
range of renal vascular resistance and 
the normal lower range of systemic 
vascular resistance are indicated as dot-
ted lines. 
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creased during ornipressin infusion from 30308 ± 
6413 to 22153 ± 3801 dyne • s" 1 • c m 5 (P < 0.05; 
Figure 1). T h e decrease of renal vascular resistance 
w a s most pronounced i n the patients w i t h the highest 
preinfusion resistance. 
Changes in Renal Function 
During the infusion of ornipressin a consider-
able improvement of renal function was achieved. 
T h e lowered creatinine clearance increased from 21 ± 
3 to 32 ± 5 m L and 32 ± 5 m L • m i n " 1 • 1.73 m " 2 body 
surface area [P < 0.05), 2 and 4 hours after onset of 
ornipressin infusion, respectively. 
T h e changes of various parameters for renal func-
tion are outlined in Figures 2 and 3. There was a 
significant increase in urine volume (from 1.0 ± 0.1 
to 1.3 ± 0.2 and 1.6 ± 0.3 m L / m i n before and 2 and 4 
P R E r— O R N I P R E S S I N — , P O S T 
hours after onset of ornipressin infusion, respec-
tively), i n u l i n clearance ( 1 8 . 6 ± 2 . 6 t o 2 9 . 6 ± 3 . 8 and 
31.6 ± 3.9 m L / m i n ) , P A H clearance (175 ± 36 to 
261 ± 54 and 246 ± 34 m L / m i n ) . Free water clear-
ance decreased significantly from - 1 5 ± 4 t o - 3 2 ± 5 
m L / h i n the second 2 hour after onset of ornipressin 
infusion. I n addition, a significant increase i n F E N a 
(0.46 ± 0.10 to 0.82 ± 0.16 and 1.3 ± 0.27%), so-
d i u m excretion (1.91 ± 0.65 to 5.2 ± 1.0 and 8.5 ± 2.8 
mval/2h) and urine sodium concentration (16.6 ± 3.4 
to 27.0 ± 6 and 36.6 ± 7.6 mval/L) occurred in re-
Figure 2. Effect of ornipressin infusion on PAH and inulin 
clearance. The clearances were measured from urine samples 
collected within 2 hours before, during, and after cessation of the 
ornipressin infusion. *P < 0.05 vs. preperiod (n = 8). 
Figure 3. Effect of ornipressin infusion on urine sodium concen-
tration, sodium excretion, and FENa. The parameters were mea-
sured or calculated from urine samples collected with 2 hours. 
The shaded areas indicate the normal range. *P < 0.05 vs. 
preperiod (n = 11). 
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sponse to ornipressin. After cessation of the infusion, 
renal function again deteriorated. 
Changes in Plasma Levels of Catecholamines, 
Renin Activity, and ANF 
T h e highly elevated plasma levels of noradren-
aline and adrenaline decreased during the ornipressin 
administration [noradrenaline, from 2.08 ± 0.30 to 
1.13 ± 0.24 ng/mL (P < 0.01); adrenaline, 0.86 ± 0.32 
to 0.54 ± 0.19 ng/mL; P < 0.05]. T h e plasma renin 
activity declined from the initially high level of 27.6 ± 
5.1 to 14.2 ± 4.0 ng • m l " 1 • h " 1 (P < 0.01). T h e atrial 
plasma level of A N F increased significantly from 
33.5 ± 5.2 to 60.0 ± 15.0 fmol/mL (P < 0.02; Figure 
4). 
A s indicated i n Figure 4, the decrease in the levels 
of noradrenaline, adrenaline, and plasma renin activ-
ity occurred uniformly i n all patients, whereas a 
variable response w a s observed concerning A N F . T h e 
atrial level of A N F increased considerably during 
ornipressin infusion i n seven patients, but slightly 
decreased i n three patients. However, these three 
patients exhibited a similar response to ornipressin as 
the 7 patients w i t h an increase i n A N F w i t h respect to 
the hemodynamic changes, the improvement of the 
renal function, and the decrease i n plasma noradrena-
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Figure 4. Individual changes in the arterial plasma levels of 
noradrenaline, adrenaline, and renin activity and in the atrial 
plasma level of ANF. Plasma samples were drawn immediately 
before and 2 hours after the onset of the ornipressin infusion. The 
mean levels of control subjects measured in our experimental 
conditions are noradrenaline, 0.26 ± 0.04 ng/mL; adrenaline, 
0.05 ± 0.01 ng/mL; plasma renin activity, 1.58 ± 0.32 ng • m L " 1 * 
h ~ \ Control values for immunoreactive A N F in atrial plasma 
samples are not available for the antibody and experimental 
conditions used in the present investigation. 
Discussion 
T h e present investigation reinforces the benefi-
cial effect of the vasopressin analogue ornipressin on 
renal dysfunction i n patients w i t h advanced liver 
cirrhosis. A s described previously (7), creatinine clear-
ance, urine volume, sodium excretion, and fractional 
elimination of sodium increased, whereas free water 
clearance decreased. I n addition, we were able to 
demonstrate that glomerular filtration and renal blood 
flow improved considerably during the infusion of 
ornipressin. I n line w i t h these functional changes, an 
improvement of the renal hemodynamic situation was 
observed. T h e increase i n systemic vascular resis-
tance was counterbalanced by a decrease i n renal 
vascular resistance. Subsequently, renal blood flow as 
w e l l as the renal fraction of the cardiac output 
increased. 
Various mechanisms may be involved in the benefi-
cial effect of a vasoconstricting compound on renal 
function i n advanced liver cirrhosis . T h e increase i n 
mean arterial pressure during ornipressin infusion, at 
least partly, could be responsible for the improvement 
of renal function. However, not all changes i n renal 
function can be explained sufficiently by the improve-
ment i n the systemic blood pressure. Data are avail-
able indicating that the increase of mean arterial 
pressure in cirrhotic patients during treatment w i t h 
head-out water immersion and exogenous infusion of 
noradrenaline was not accompanied by significant 
changes in the clearance of creatinine, i n u l i n , and 
P A H , whereas sodium and water excretion signifi-
cantly increased (9). Therefore, additional mecha-
nisms appear to be of importance. O n e of the striking 
results in our investigation was the stimulation of 
A N F release i n the majority of the patients, accompa-
nied by a decrease i n the plasma levels of catechol-
amines and plasma renin activity. Release of A N F into 
circulation is mainly stimulated by manipulations 
k n o w n to increase atrial pressure, such as acute 
volume expansion, water immersion, and vasocon-
strictor substances (30,31). I n h u m a n s and rats, the 
administration of phenylephrine, vasopressin, or an-
giotensin II in hypertensive doses produce an immedi-
ate rise i n A N F (32-34) . E v e n increases i n atrial 
pressure as small as 2 m m Hg are sufficient to 
stimulate A N F secretion (33). I n the present study, 
central venous pressure increased by about 2 m m Hg, 
representing an adequate st imulus. Various s t imuli 
have been s h o w n to stimulate the release of A N F i n 
advanced liver cirrhosis, inc luding volume expansion 
after peritoneovenous shunting (35,36), head-out w a -
ter immersion (37), and indirectly, large-volume para-
centesis (38), but the extent of this release appears to 
be blunted (37). These findings indicate that i n ad-
vanced liver cirrhosis the atrial pool of prohormone 
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and/or releasable A N F and/or its synthesis rate may be 
d i m i n i s h e d . Consequently, a prolonged stimulation of 
A N F release, as in the case of a 2-hour infusion period 
of ornipressin, may result i n an attenuated amount of 
releasable A N F and may explain the decrease of A N F 
i n some of the patients. Actual ly , i n these patients the 
atrial level of A N F was i n the lower range already 
before the onset of ornipressin infusion. Furthermore, 
other mechanisms have to be considered w h i c h influ-
ence A N F plasma concentrations, s u c h as enzymatic 
degradation and clearance of the peptide from the 
circulat ion (39). 
Whether the increased amount of circulating A N F 
c o u l d have contributed to the increase i n natriuresis 
st i l l remains a crucial question. Several pharmacolog-
ical studies point to a reduced responsiveness to 
exogenous A N F i n cirrhosis w i t h ascites i n h u m a n s 
a n d rats (40-43) . T h e blunted renal response to A N F 
seems to be related to the altered systemic hemody-
namics of cirrhosis and excessive antagonism by 
antinatriuretic factors, s u c h as the renin-angiotensin-
aldosteron system. Because of its blood pressure 
lowering effect and hence further deterioration of the 
systemic hemodynamics , the therapeutic efficacy of 
exogenous A N F or a synthetic analogue has been 
s h o w n to be limited i n patients w i t h cirrhosis compli-
cated by renal dysfunction (40,41,43,44). T h e impor-
tant role of arterial hypotension i n the d iminished 
renal response to A N F has been s h o w n in rats w i t h 
C C l 4 - i n d u c e d cirrhosis as w e l l as in portal hyperten-
sive rats, where the renal effects of A N F were en-
hanced on normalization of arterial pressure by either 
angiotensin II or ornipressin (42,45). Furthermore, the 
blunted natriuretic response to A N F in chronic bile-
duct—ligated rats wi th cirrhosis and ascites has been 
reversed by bilateral renal denervation, indicating an 
involvement of increased renal sympathetic nerve 
activity i n this phenomenon (46). Because a normal-
ization of mean arterial pressure as w e l l as an attenua-
tion of the sympathetic nervous system activation was 
achieved during the infusion of ornipressin i n the 
present study, the renal response to the increased 
plasma levels of endogenous A N F might have been 
preserved, and the increased release of A N F could 
have contributed to the enhanced natriuresis during 
ornipressin infusion. However, an impaired natri-
uretic response to A N F has been recently demon-
strated i n isolated perfused kidneys of rats w i t h 
C C l 4 - i n d u c e d cirrhosis (47). 
A predominant effect of ornipressin i n functional 
renal failure i n liver cirrhosis is the escape from 
extreme renal vasoconstriction. T h e decrease i n renal 
vascular resistance can be at least partly explained by 
the reduction i n sympathetic nervous system activity 
and renin release in response to ornipressin as i n d i -
cated by the considerable decrease i n the plasma 
levels of noradrenaline and adrenaline and plasma 
renin activity. O n the other h a n d a participation of 
A N F in this phenomenon might be expected. A N F has 
been s h o w n to be a potent and relatively specific renal 
vasodilator substance (48,49). T h e influence of this 
atrial peptide on renal hemodynamics seems to be 
unique as it causes a dilation of the blood vessels 
w h i c h supply the glomeruli and a vasoconstriction of 
the efferent arterioles (50) and, consequently, an 
increase of filtration fraction. 
Recent findings point to the involvement of splanch-
nic vasodilation i n the development of the functional 
renal failure i n advanced cirrhosis. T h e systemic 
hyperdynamic circulatory status has been s h o w n to 
be associated w i t h a reduced flow to extrasplanchnic 
territories indicating a diversion of large fractions of 
the cardiac output from the vasoconstricted renal and 
femoral vascular beds to other vasodilated vascular 
beds, especially to the splanchnic area (16). T h e 
splanchnic vasodilation inspite of a considerably 
elevated sympathetic tone is probably related to the 
following phenomenon. During continued stimula-
tion of sympathetic vasoconstrictor fibers to splanch-
nic vessels, an increase i n intestinal blood flow occurs 
because of an autoregulatory escape (51). Therefore, 
the splanchnic vascular bed may not be sufficiently 
protected against the action of potent vasodilator 
compounds, w h i c h accumulate i n liver failure (12,17). 
A s potent vasoconstrictor substances i n the splanch-
nic area (18), vasopressin and its analogues w i t h 
preferential vasoconstrictor action have the potential 
to counteract the profound vasodilation in the splanch-
nic beds. I n addition, during ornipressin infusion, the 
vasoconstriction i n renal and femoral beds was proba-
bly attenuated by reducing the extreme activation of 
the sympathetic nervous system. Thereby, the blood 
flow was shifted from splanchnic territories to extra-
splanchnic areas as underl ined by the increase in the 
renal fraction of the cardiac output. 
O n e of the m a i n factors responsible for the efficacy 
of ornipressin i n improving renal function appears to 
be the suppression of the increased activity of the 
sympathetic nervous and of the renin-angiotensin 
systems. T h i s pronounced suppression can be at least 
partly explained by the increase i n mean arterial 
pressure, thereby altering the arterial baroreceptor 
response. O n the other hand, A N F may contribute to 
this suppression, because A N F is k n o w n to inhibit 
renin release (52,53) as wel l as sympatho-adrenal 
activity (54,55). 
I n summary, the present results suggest the follow-
ing mechanisms to be involved i n the beneficial effect 
of ornipressin on renal failure associated w i t h ad-
vanced liver cirrhosis. T h e improvement of renal 
hemodynamics as indicated by a decrease of renal 
vascular resistance and an increase of renal blood 
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flow and of the renal fraction of cardiac output 
supposedly plays a key role. T h e s e changes appear to 
be l inked to a shift of blood flow from splanchnic to 
extrasplanchnic territories, increase i n mean arterial 
pressure, and to the suppression of the profound 
activation of the sympathetic nervous system and the 
renin-angiotensin axis. T h e contribution of A N F to 
this significant improvement is less defined. Because 
a variable response in the release of A N F occurred and 
the atrial plasma level of A N F even decreased i n three 
patients, A N F is not necessarily a prerequisite for the 
observed changes. 
T h e findings of the present investigation are of 
considerable c l inica l relevance. Treatment w i t h orni-
pressin represents an alternative approach to the 
management of functional renal failure i n advanced 
liver cirrhosis and might help to avoid or postpone the 
use of extracorporeal el imination techniques as an 
ultimate step. I n cirrhotic patients, these procedures 
are afflicted w i t h potential disadvantages, inc luding 
dialysis- induced hypotension, increased risk of infec-
tion, worsening of coagulopathy, and changes i n 
drug-protein binding (56). I n addition, the use of 
ornipressin might be applied for optimizing the c l i n i -
cal condition of patients awaiting liver transplanta-
tion. T h i s has been already demonstrated i n a single 
patient (7). Further studies are i n progress to evaluate 
the effect of long-term treatment w i t h ornipressin. 
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